|Age:||1 to 21 years old|
|Keywords:||childhood cancer, pediatric cancer, pediatric tumor, Pediatric Relapsed or Refractory Advanced Solid Tumors, genetic testing, cancer|
|Type:||Procedure study, Phase 2|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.
= 50% of the pelvis; >= 42 days if other substantial bone marrow (BM) radiation; note: radiation may not be delivered to "measurable disease" tumor site(s) being used to follow response to subprotocol treatment
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.